---
title: "Designing Population Health Studies"
subtitle: "March 31, April 2 2025<br> Eric Delmelle"
format: revealjs
---
  
  ```{=html}
<style>
  .circle {
    background-color: #FFCCCB;
      border: 2px solid teal;
    border-radius: 50%;
    color: teal;
    width: 75px;
    height: 75px;
    display: inline-block;
    text-align: center;
    line-height: 75px;
    vertical-align: middle;
    margin-right: 5px;
  }

.highlight-box {
  background-color: yellow;
  padding: 10px;
  border-radius: 5px;
}

ul {
  font-size: 85%;
}

ul ul {
  font-size: 75%;
}
</style>
  ```

![](imgs/chapter6.png){fig-align="center" width="327"}



# <span style="text-align: center; color: blue;">Chapter Overview</span>

- Research design fundamentals in epidemiology and public health  
- Measurement validity and reliability  
- Error and bias in population health research  
- Study design approaches:  
  - Cross-sectional  
  - Case-control  
  - Cohort  
  - Experimental  
- Qualitative methods and their integration with quantitative approaches  
- Ethical considerations in population health research  

---

## <span class="circle">1</span> <span style="color: teal;">A Matter of Measurement</span>

### Primary vs. Secondary Data

**<span style="color: brown;">Primary data</span>:**  
  - Data collected specifically for the purpose of the study.

**<span style="color: brown;">Secondary data</span>:**  
  - Data collected for other purposes but reorganized and reanalyzed.

**Examples:**  
- Health insurance claims data  
- Employment records  
- National health surveys

---

## <span class="circle">2</span> <span style="color: teal;">Primary vs. Secondary Data</span>

::: {.columns}
::: {.column width="60%"}

- **Primary data**
  - Collected specifically for a new study
  - Controlled by the researcher
  - Tailored to answer specific research questions

- **Secondary data**
  - Pre-existing data collected for another purpose
  - Often large-scale and readily available
  - May require cleaning or transformation


:::
::: {.column width="40%"}
![](https://images.unsplash.com/photo-1581091226033-d5c48150dbaa?ixlib=rb-4.0.3&auto=format&fit=crop&w=2670&q=80)
:::
:::


While primary data offers control and precision, secondary data can save time and resources.


---

## <span class="circle">3</span> <span style="color: teal;">Levels of Measurement</span>

::: {.scrollable style="font-size: 0.7em;"}
| Level        | Description                      | Example                                     | Operations                    |
|--------------|----------------------------------|---------------------------------------------|-------------------------------|
| **Nominal**  | Categories with no ranking       | Blood type, Sex                             | Equality/inequality           |
| **Ordinal**  | Ordered categories               | Health self-rating: excellent, good, fair, poor | Greater than/less than        |
| **Interval** | Equal units, no true zero        | Temperature in °C                          | Addition/subtraction          |
| **Ratio**    | Equal units with true zero       | Weight, Blood pressure                      | Multiplication/division       |
:::

::: {.scrollable style="font-size: 0.7em;"}
Understanding measurement levels is crucial for selecting appropriate statistical analyses. *A variable can always be reduced to a lower level of measurement* (continuous to categorical), *but not elevated* (categorical to continuous).
:::


## <span class="circle">4</span> <span style="color: teal;">Ecological Studies and Fallacy</span>

::: {.columns}
::: {.column width="55%"}
::: {.scrollable style="font-size: 0.85em;"}

- **Unit of analysis:** Group (e.g., city-level data)
- **Examples:**
  - Community fluoride levels and dental caries
  - Countries' smoking rates and lung cancer rates
- **Ecological fallacy:** Attributing group-level associations to individuals
- **Example:**
  - Classrooms with more women had higher average grades
  - But individual-level analysis showed men had higher grades in each classroom
:::
:::

::: {.column width="45%"}
::: {.scrollable style="font-size: 0.55em;"}
| Classroom A | Classroom B | Classroom C |
|-------------|-------------|-------------|
| F 70        | F 65        | F 65        |
| F 70        | F 70        | F 70        |
| F 70        | F 70        | F 80        |
| F 75        | F 75        | F 80        |
| F 70        | F 80        | **M 70**    |
| F 80        | F 85        | **M 75**    |
| F 80        | **M 80**    | **M 75**    |
| F 80        | **M 80**    | **M 80**    |
| **M 95**    | **M 85**    | **M 85**    |
| **M 100**   | **M 90**    | **M 90**    |
| Class Mean  |             |             |
| F 74, M 98, FM: 79 | F 74, M 84, FM: 78 | F 74, M 79, FM: 77 |
:::
:::
:::

---

## <span class="circle">5</span> <span style="color: teal;">Variables and Levels of Measurement</span>

::: {.columns}
::: {.column width="60%"}
::: {.scrollable style="font-size: 0.85em;"}
* **Categorical variables:**
   * *Dichotomous* (e.g., male/female)
   * *Polytomous* (e.g., blood type)
   * *Nominal* (no implied order)
   * *Ordinal* (ranked, e.g., "good" > "fair")
* **Continuous variables:**
   * *Interval scale* (e.g., temperature in Celsius)
   * *Ratio scale* (e.g., body weight, height)

Note: Continuous variables can be converted to categorical, but not vice versa.
:::
:::
::: {.column width="40%"}
![](https://images.unsplash.com/photo-1551288049-bebda4e38f71?ixlib=rb-4.0.3&auto=format&fit=crop&w=1770&q=80)
:::
:::


---

## <span class="circle">6</span> <span style="color: teal;">Types of Research Design</span>

**Key concepts to distinguish studies:**

- **Purpose**: Descriptive vs. analytical
- **Investigator control**: Observational vs. interventional
- **Directionality**: Forward vs. backward
- **Sample selection**: Based on exposure, disease, or neither
- **Timing**: Prospective vs. retrospective

**Study Types:**
- Cross-sectional
- Case-control
- Retrospective cohort
- Prospective cohort
- Randomized controlled trial (RCT)


----

## <span class="circle">7</span> <span style="color: teal;">Basic Terminology: Exposure and Disease</span>

::: {.columns}
::: {.column width="60%"}
- **E** = "Exposure"
  - Risk factor (e.g., smoking, occupational hazard)
  - Intervention (e.g., drug, prevention program)

- **D** = "Disease" or outcome
  - Disease, injury, death
  - Any health-related outcome

- **E₀** and **D₀** = Absence of exposure/disease
- **E₁** and **D₁** = Presence of exposure/disease
:::

::: {.column width="40%"}
![](https://images.unsplash.com/photo-1589279003513-467d320f47eb?ixlib=rb-4.0.3&auto=format&fit=crop&w=1335&q=80)
:::
:::

::: {.notes}
This basic E and D framework helps illustrate the logic behind different epidemiological study designs.
:::

---

## <span class="circle">8</span> <span style="color: teal;">Study Designs Summary</span>

::: {.scrollable style="font-size: 0.65em;"}
| Study Type              | Purpose              | Control         | Directionality | Sample Selection     | Timing       |
|-------------------------|----------------------|------------------|----------------|----------------------|--------------|
| **Cross-sectional**     | Descriptive/Analytical | Observational   | Concurrent     | Representative sample | Retrospective |
| **Case-control**        | Analytical           | Observational   | Backward       | Based on disease     | Retrospective |
| **Retrospective cohort**| Analytical           | Observational   | Forward        | Based on exposure    | Retrospective |
| **Prospective cohort**  | Analytical           | Observational   | Forward        | Based on exposure    | Prospective   |
| **Randomized control trial** | Analytical     | Interventional  | Forward        | Based on exposure    | Prospective   |
:::


---

## <span class="circle">9</span> <span style="color: teal;">Cross-Sectional Studies</span>

::: {.columns}
::: {.column width="55%"}
::: {.scrollable style="font-size: 0.75em;"}
- Also called **prevalence studies**
- Exposure and outcome assessed **simultaneously**
- Can be descriptive or analytical
- Provides a "snapshot" of a population
- Relatively quick and inexpensive

**Limitations**:

- Cannot establish temporal sequence

- Only includes survivors of disease

- Not suitable for rare diseases
:::
:::

::: {.column width="45%"}
![](imgs/crossSection.jpg)

*A snapshot in time: both exposure and outcome measured simultaneously*
:::
:::


---

## <span class="circle">10</span> <span style="color: teal;">In-class exercise</span>
---

## <span class="circle">11</span> <span style="color: teal;">Case-Control Analysis</span>

::: {.columns}
::: {.column width="60%"}
::: {.scrollable style="font-size: 0.8em;"}
- Cannot directly compute relative risk
- Use **odds ratio (OR)** as an estimate:

$$OR = \frac{ad}{bc}$$

- In a 2×2 table:

$$
\begin{array}{|c|c|c|} \hline
 & D_1 & D_0 \\ \hline
E_1 & a & b \\ \hline
E_0 & c & d \\ \hline
\end{array}
$$

- When disease is rare, OR ≈ RR
:::
:::


::: {.column width="40%"}
::: {.scrollable style="font-size: 0.8em;"}
![](imgs/caseControl.png)

What is happening here?
:::
:::
:::

---

## <span class="circle">12</span> <span style="color: teal;">Cohort Studies</span>

::: {.columns}
::: {.column width="55%"}
- Start with **exposure status** (E₁ and E₀)
- Follow forward to observe outcome
- Two types:
  - **Prospective**: Start now, follow into future
  - **Retrospective**: Look back at historical exposure
- Can study multiple outcomes
- Directly computes incidence and relative risk
:::

::: {.column width="45%"}
![](imgs/cohort.jpg)

*Following groups forward from exposure to outcome*
:::
:::


----

## <span class="circle">13</span> <span style="color: teal;">Cohort Analysis</span>

::: {.columns}
::: {.column width="60%"}
::: {.scrollable style="font-size: 0.8em;"}
- **Relative Risk (RR)** quantifies association between exposure and outcome:

$$RR = \frac{a/(a+b)}{c/(c+d)}$$

- In a 2×2 table:

$$
\begin{array}{|c|c|c|} \hline
 & D_1 & D_0 \\ \hline
E_1 & a & b \\ \hline
E_0 & c & d \\ \hline
\end{array}
$$
:::
:::
::: {.column width="40%"}
::: {.scrollable style="font-size: 0.8em;"}
- Allows for:
  - Direct incidence calculation
  - Assessment of multiple outcomes
  - Use with rare exposures



**Challenges:**

- Time-consuming and costly

- Potential for loss to follow-up

- Not ideal for rare diseases

- Diagnostic changes over time may affect results
:::
:::
:::

---

## <span class="circle">14</span> <span style="color: teal;">Randomized Controlled Trials (RCTs)</span>

::: {.columns}
::: {.column width="55%"}
::: {.scrollable style="font-size: 0.8em;"}
- **Gold standard** for assessing causal relationships
- Participants randomly allocated to intervention (E₁) or control (E₀)
- Minimizes confounding and bias through:
  - Randomization
  - Blinding (single, double)
- Can be conducted at individual or group level

:::
:::
::: {.column width="45%"}
::: {.scrollable style="font-size: 0.8em;"}

**Phases of clinical trials:**

- **Phase I:** Safety and dosage (small sample)

- **Phase II:** Effectiveness and side effects

- **Phase III:** Confirm effectiveness, monitor adverse reactions (RCT)

- **Phase IV:** Post-marketing surveillance

*Randomization helps balance known and unknown confounders.*
:::
:::
:::


---


## <span class="circle">15</span> <span style="color: teal;">Validity and Reliability</span>

::: {.columns}
::: {.column width="50%"}
::: {.scrollable style="font-size: 0.8em;"}
**Measurement Validity**

- **Face validity**: Appears reasonable on the surface

- **Content validity**: Covers full scope of concept

- **Construct validity**: Reflects theoretical concept

- **Criterion validity**: Correlates with external standard

- **Concurrent validity**: Correlates with present condition

- **Predictive validity**: Forecasts future outcome
:::
:::

::: {.column width="50%"}
::: {.scrollable style="font-size: 0.8em;"}
**Study Validity**

- **Internal validity**: Results valid for study sample

- **External validity**: Results generalize to other populations

**Reliability**

- **Test-retest**: Same test, different times

- **Inter-observer**: Different observers agree

- **Intra-observer**: Same observer consistent over time
:::
:::
:::

---

## <span class="circle">16</span> <span style="color: teal;">Reliability vs. Validity</span>

::: {.columns}
::: {.column width="60%"}
- **Reliability** = consistency of measurement
- **Validity** = accuracy of what is intended to be measured
- A tool can be reliable but not valid
- A tool cannot be valid if it is not reliable
:::

::: {.column width="40%"}
![Target analogy for validity and reliability](https://upload.wikimedia.org/wikipedia/commons/thumb/5/5d/Reliability_and_validity.svg/1024px-Reliability_and_validity.svg.png)
:::
:::

---

## <span class="circle">17</span> <span style="color: teal;">Types of Error</span>

::: {.columns}
::: {.column width="50%"}
**Random Error**

- Caused by chance or sampling variation

- Affects **precision**

- Can be reduced by increasing sample size

- Produces unpredictable fluctuations
:::

::: {.column width="50%"}
**Systematic Error (Bias)**

- Consistent, repeatable error due to flaws in design or measurement

- Affects **validity**

- Not reduced by increasing sample size

- Must be addressed in study design
:::
:::

---
  
## <span class="circle">18</span> <span style="color: teal;">Major Types of Bias</span>
  
::: {.panel-tabset}
### Selection Bias
- Systematic differences between those selected and not selected
- Examples:
  - Low response rate
- Healthy worker effect
- Volunteer bias
- Berkson's bias (hospital sampling)
  - Loss to follow-up
  - Survivor bias


### Information Bias
- Measurement error or misclassification
- Examples:
  - Recall bias
  - Observer/interviewer bias
  - Social desirability bias
  - Instrument bias
  - Diagnostic suspicion bias


### Confounding
- Third variable distorts exposure-outcome relationship
- Must be:
  1. Associated with exposure
  2. Risk factor for the outcome
  3. Not an intermediate step in the causal path
:::




---

## <span class="circle">19</span> <span style="color: teal;">Controlling for Confounding</span>

::: {.columns}
::: {.column width="50%"}
**At Design Stage**

1. **Randomization**  
   - Evenly distributes confounders across groups

2. **Restriction**  
   - Limit study to specific subgroup
   
3. **Matching**  
   - Pair participants with similar characteristics
:::

::: {.column width="50%"}
**At Analysis Stage**

4. **Stratification**  
   - Analyze within homogeneous strata  
   - Mantel-Haenszel summary estimate

5. **Multivariable Modeling**  
   - Include confounders as covariates  
   - Logistic regression, Cox models
:::
:::



---

## <span class="circle">20</span> <span style="color: teal;">Effect Modification (Interaction)</span>

::: {.columns}
::: {.column width="60%"}
::: {.scrollable style="font-size: 0.7em;"}
- Occurs when the effect of exposure differs across levels of a third variable
- **Not the same as confounding**
- Can be additive or multiplicative
- **Additive Model:**  
  $$RREM = RRE + RRM - 1$$
- **Multiplicative Model:**  
  $$RREM = RRE \times RRM$$
- Interpretation:
  - If RREM > expected → **synergism**
  - If RREM < expected → **antagonism**
:::
:::

::: {.column width="40%"}
**Example:** Asbestos and smoking on lung cancer risk
![Interaction models](imgs/effectModification.png)
:::
:::



---


## <span class="circle">21</span> <span style="color: teal;">Qualitative Methods</span>

::: {.columns}
::: {.column width="55%"}
- Originates from the social sciences
- Explores perceptions, beliefs, experiences
- Often used to:
  - Understand lived experiences
  - Explore context and meaning
  - Inform survey and tool development
- **Common techniques:**
  - In-depth interviews
  - Focus groups
  - Participant observation
  - Document analysis
:::

::: {.column width="45%"}
![](https://images.unsplash.com/photo-1552664730-d307ca884978?ixlib=rb-4.0.3&auto=format&fit=crop&w=1770&q=80)

*Mixed methods combine qualitative insight with quantitative data.*
:::
:::



---

## <span class="circle">22</span> <span style="color: teal;">Types of Qualitative Methods</span>

::: {.panel-tabset}
### Observation
- **Participant observation**: Researcher immersed in environment
- Captures real behavior and interactions
- Varies in degree of participation

### Interviews
- **Structured**: Same questions for all
- **Semi-structured**: Flexible, guided
- **In-depth**: Deep exploration
- **Focus groups**: Group discussion dynamics

### Document Analysis
- Systematic review of written or visual materials
- Examples:
  - Public records, policy reports
  - Personal journals, media, videos
:::




---

## <span class="circle">23</span> <span style="color: teal;">Integrating Qualitative & Quantitative Methods</span>

::: {.columns}
::: {.column width="60%"}
::: {.scrollable style="font-size: 0.7em;"}
**Ways to integrate qualitative methods:**

1. **Pre-study**: To develop hypotheses or instruments

2. **During study**: To explain unexpected results

3. **Post-study**: To interpret and validate findings

4. **Standalone**: As an alternative or complement to quantitative

**Example: Regional Health Needs Assessment**

- **Quantitative**: Epidemiologic data, service access

- **Qualitative**: Focus groups with residents, interviews with key informants
:::
:::

::: {.column width="40%"}
![](https://images.unsplash.com/photo-1544027993-37dbfe43562a?ixlib=rb-4.0.3&auto=format&fit=crop&w=1770&q=80)

*Combining methods gives depth and context.*
:::
:::

---

## <span class="circle">24</span> <span style="color: teal;">Ethical Considerations</span>

::: {.columns}
::: {.column width="50%"}
**Four Ethical Principles:**

1. **Autonomy** – Respect for individuals

2. **Beneficence** – Maximize benefits

3. **Non-maleficence** – Do no harm

4. **Justice** – Fair treatment and burden distribution
:::

::: {.column width="50%"}
**Research Protections:**

- Informed consent

- Confidentiality

- Data security

- Vulnerable populations

- Institutional Review Boards (IRBs)

- Research integrity and transparency
:::
:::

---

## <span class="circle">25</span> <span style="color: teal;">Key Takeaways</span>

::: {.columns}
::: {.column width="60%"}
- Choose the study design that best answers your research question
- Recognize and control for bias and confounding
- Understand the role of validity and reliability
- Combine methods when appropriate
- Always prioritize ethics and participant rights

:::

::: {.column width="40%"}
::: {.scrollable style="font-size: 0.7em;"}
![](https://images.unsplash.com/photo-1517245386807-bb43f82c33c4?ixlib=rb-4.0.3&auto=format&fit=crop&w=1770&q=80)

> “No method is inherently superior—it all depends on the research question.” – T. Kue Young
:::
:::
:::

